The 2011 Census is recruiting Area Managers

BAMA :: British Arab Medical Association

Welcome...

BAMA is a professional, non-political and not for profit organisation
BAMA's aim is to provide a supportive framework for healthcare societies and personnel of Arabic origin living and working in the UK and abroad. BAMA supports, effectively represents, and fascilitates its members' activities in all aspects of their life.

BAMA main objectives are ...

PROMOTION of scientific practice in the UK and Arabic World (workshops, conferences, journals, CPD credits, etc.)
Effective NETWROKING between members (annual meetings, regional representatives, effective links to Arabic States Medical schools and Universities, etc.)
CAREER ADVICE and counselling for Members or any other requesting person (CV check, curriculum advice, Evidence-based Medicine practice advice, etc.)
Effective REPRESENTATION to develop professional relationships (GMC, BMA, Royal Colleges, DoH, Health Ministries,Universities & Medical Schools, etc.)
MAINTAINANCE and PROMOTION of the Arabic medical and cultural heritage
Taking ethical stand on human rights issues nationally and internationally

Health News from NHS Choices

Diabetes 'increases birth defect risk'

“Diabetic mothers-to-be have high risk of giving birth to children with congenital abnormality,” The Guardian said today.

The news is based on UK research that compared...
Mutation linked to 42% rise in stroke risk

A “single genetic mutation can double your risk of stroke”, the Daily Mail has reported. The newspaper added that scientists hope the discovery could lead...
Sunday hospital admissions 'a bigger risk'

A new study has found that “patients are more likely to die in hospital if they are admitted at the weekend”, according to BBC News....

BBC News

VIDEO: Cancer overshadowed in DR Congo
The Democratic Republic of Congo faces so many challenges battling diseases such as malaria, AIDS and cholera that cancer has been pushed off the radar.
VIDEO: Pakistan investigates drugs deaths
Professor Javed Akram, who is leading the clinical investigation into contaminated medicines in Pakistan, explained how the problem was identified.
Transplant jaw made by 3D printer
An 83-year-old woman is fitted with a jaw made by a 3D printer in what doctors say is the first operation of its kind.
AUDIO: 'Wonderful' to have sight back
Katie Piper told Radio 5 live about being able to see after she was blinded in one eye after an acid attack.
Campaign to cut smoking in cars
A campaign to stop people smoking in cars when carrying children - and which could pave the way for a ban - is launched by the Welsh government.

Medical News Today

Bad Immunity Genes - Why do They Survive?
New evidence has been discovered by biologists at the University of Utah as to why people, mice and other vertebrate animals carry thousands of different genes to create major histocompatibility complex (MHCs) proteins, despite the fact that some of those genes make humans vulnerable to autoimmune diseases and infections. Findings from the study will be published online the week of February 6, 2012, in the journal Proceedings of the National Academy of Sciences. MHC proteins are found on the surface of most cells in vertebrates and define an individual's tissue type...
Green Tea Protects Against Functional Disability Linked To Aging
Regular green tea drinkers have a lower risk of developing functional disability, researchers from Tohoku University Graduate School of Medicine, Sendai, Japan, reported in the American Journal of Clinical Nutrition. Functional disability refers to problems with daily chores and activities, such as bathing or dressing. As background information, the authors explained that prior studies had found that consuming green tea reduced the risk of diseases associated with functional disability, such as osteoporosis, cognitive impairment and stroke...
Merck Has Positive Results With New Insomnia Drug
Merck has announced positive results in a phase 3 trial of its insomnia drug. It's a key player in the companies up and coming products, especially considering the loss of patent protection on its top drugs for asthma and allergys. The experimental drug known as suvorexant, uses a new mechanism created to help people sleep, but at the same time aiming to mitigate side effects associated with popular sleep aids. Analysts think that annual sales of the drug could top $500 million within several years. Peter S...